Work

Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer

Year: 2017
Type: review
Abstract: Mesenchymal stem cells (MSCs), an ideal cell source for regenerative therapy with no ethical issues, play an important role in diabetic foot ulcer (DFU). Growing evidence has demonstrated that MSCs transplantation can accelerate wound closure, ameliorate clinical parameters, and avoid amputation. In this review, we clarify the mechanism of preclinical studies, as well as safety and efficacy of clinical trials in the treatment of DFU. Bone marrow-derived mesenchymal stem cells (BM-MSCs), compared with MSCs derived from other tissues, may be a suitable cell type that can provide easy, effective, and cost-efficient transplantation to treat DFU and protect patients from amputation.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,760
OpenAlex ID: W2594200592
FWCI: 1.53
Cites: 109
Cited by: 192
Related to: 10